Role of Pelvic MRI in Identifying Causes of Menorrhagia
Pelvic MRI is highly valuable as a second-line imaging modality for identifying causes of menorrhagia when ultrasound findings are inconclusive or further characterization is needed. 1
Initial Diagnostic Approach
First-line imaging: Transvaginal ultrasound (TVUS)
When to consider MRI:
- When ultrasound is inconclusive or limited by:
- Patient body habitus
- Uterine position (e.g., retroverted)
- Presence of multiple fibroids
- Limited visualization of endometrium
- Need for better characterization of findings
- When ultrasound is inconclusive or limited by:
Advantages of MRI for Menorrhagia Evaluation
Superior tissue characterization:
Specific structural causes identifiable by MRI:
Fibroids (leiomyomas)
Adenomyosis
Endometrial abnormalities
- Can identify endometrial hyperplasia, polyps, and cancer
- Helps evaluate endometrial-myometrial interface 1
Malignancies
Optimal MRI Protocol for Menorrhagia
Key sequences:
Contrast considerations:
Clinical Algorithm for Menorrhagia Imaging
Start with TVUS ± sonohysterography
- If findings are conclusive → proceed with appropriate treatment
- If findings are inconclusive or limited → proceed to MRI
Pelvic MRI
- Without and with contrast when malignancy is suspected
- Without contrast may be sufficient for evaluating fibroids and adenomyosis
Treatment planning based on imaging findings
- Medical management for diffuse pathologies
- Targeted interventions for focal lesions
- Surgical planning when indicated
Common Pitfalls to Avoid
- Relying solely on ultrasound when findings are inconclusive or limited
- Failing to use diffusion-weighted imaging in MRI protocols, which significantly improves diagnostic accuracy
- Not considering adenomyosis as a cause of menorrhagia when fibroids are present
- Overlooking the need for endometrial sampling in appropriate cases, regardless of imaging findings
MRI should not be used as a first-line imaging modality for all patients with menorrhagia but reserved for cases where ultrasound is inconclusive or additional information is needed for treatment planning.